The Agency for Medicines and Health Products, the Spanish health regulator, has just approved the trial of the second segment of Phase 3 for Johnson & Johnson COVID-19 vaccine in 9 hospitals across the country.  The New Brunswick based drug maker will also be commencing a 30,000-patient trial in the UK, long with many other countries proceeding.  

Read more here.  

More on: